This work depends on public perceptions. We are not doing well at informing the public. In terms of regulation, the new gene technology Bill gives the public less access than they have now. You have to get the benefits to the consumers, not the companies. It is not going to happen in a hurry.
People don t object to genetically modified medicines.
The Swiss, in a referendum, almost banned genetic engineering. There is little known about genes. There is not sufficient hard data. This has to be solved before the technology is applied. The testing of plants, especially foods, needs to be rigorous.